Ensign Peak Advisors
DNA.WS

Ensign Peak Advisors’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Ensign Peak Advisors’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,100
Closed -$454 – 1728
2024
Q2 		$454 Hold
16,100
– – ﹤0.01% 1711
2024
Q1 		$1.45K Hold
16,100
– – ﹤0.01% 1724
2023
Q4 		$1.7K Hold
16,100
– – ﹤0.01% 1738
2023
Q3 		$3.62K Hold
16,100
– – ﹤0.01% 1755
2023
Q2 		$4.22K Hold
16,100
– – ﹤0.01% 1760
2023
Q1 		$2.9K Hold
16,100
– – ﹤0.01% 1771
2022
Q4 		$3.22K Hold
16,100
– – ﹤0.01% 1786
2022
Q3 		$12K Hold
16,100
– – ﹤0.01% 2307
2022
Q2 		$8K Hold
16,100
– – ﹤0.01% 2150
2022
Q1 		$14K Hold
16,100
– – ﹤0.01% 2186
2021
Q4 		$49K Hold
16,100
– – ﹤0.01% 2144
2021
Q3 		$54K Buy
+16,100
New +$57.3K ﹤0.01% 1829

Other funds holding DNA.WS

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Ensign Peak Advisors's DNA.WS Position: Q3 2024 in Review

Ensign Peak Advisors sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2024, closing a stake of 16,100 shares — an estimated $454 sold.

Ensign Peak Advisors first reported a position in DNA.WS in Q3 2021 and held it in 12 quarters. The position peaked at $54K in Q3 2021. 5 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2024.

  • Ensign Peak Advisors reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 16,100 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2024, an estimated $454.
  • Ensign Peak Advisors first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 12 quarters.
  • Ensign Peak Advisors's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $54K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2024.

Based on Ensign Peak Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.